167 related articles for article (PubMed ID: 32781755)
1. FGFR4 Gene Polymorphism Reduces the Risk of Distant Metastasis in Lung Adenocarcinoma in Taiwan.
Li JP; Huang HC; Yang PJ; Chang CY; Chao YH; Tsao TC; Huang H; Hung YC; Hsieh MJ; Yang SF
Int J Environ Res Public Health; 2020 Aug; 17(16):. PubMed ID: 32781755
[TBL] [Abstract][Full Text] [Related]
2. Association of Fibroblast Growth Factor Receptor 4 Genetic Polymorphisms With the Development of Uterine Cervical Cancer and Patient Prognosis.
Chen TH; Yang SF; Liu YF; Lin WL; Han CP; Wang PH
Reprod Sci; 2018 Jan; 25(1):86-93. PubMed ID: 28378614
[TBL] [Abstract][Full Text] [Related]
3. Involvement of FGFR4 Gene Variants on the Clinicopathological Severity in Urothelial Cell Carcinoma.
Tsay MD; Hsieh MJ; Lee CY; Wang SS; Chen CS; Hung SC; Lin CY; Yang SF
Int J Environ Res Public Health; 2019 Dec; 17(1):. PubMed ID: 31878098
[TBL] [Abstract][Full Text] [Related]
4. An updated meta-analysis of the association between fibroblast growth factor receptor 4 polymorphisms and susceptibility to cancer.
Moazeni-Roodi A; Sarabandi S; Karami S; Hashemi M; Ghavami S
Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33017009
[TBL] [Abstract][Full Text] [Related]
5. Fibroblast growth factor receptor 4 polymorphism is associated with liver cirrhosis in hepatocarcinoma.
Sheu MJ; Hsieh MJ; Chiang WL; Yang SF; Lee HL; Lee LM; Yeh CB
PLoS One; 2015; 10(4):e0122961. PubMed ID: 25860955
[TBL] [Abstract][Full Text] [Related]
6.
Li JP; Hsieh MJ; Chou YE; Chao YH; Tsao TC; Yang SF
Int J Environ Res Public Health; 2020 Apr; 17(9):. PubMed ID: 32344833
[TBL] [Abstract][Full Text] [Related]
7. Prognostic implications of fibroblast growth factor receptor 4 polymorphisms in primary breast cancer.
Wei W; You Z; Sun S; Wang Y; Zhang X; Pang D; Jiang Y
Mol Carcinog; 2018 Aug; 57(8):988-996. PubMed ID: 29603419
[TBL] [Abstract][Full Text] [Related]
8. Potential Impacts of
Lee KL; Lai TC; Wang YC; Shih PC; Yang YC; Tsao TC; Liu TC; Wen YC; Chang LC; Yang SF; Chien MH
Genes (Basel); 2021 Mar; 12(3):. PubMed ID: 33802737
[TBL] [Abstract][Full Text] [Related]
9. FGFR4 Gly388Arg polymorphism may affect the clinical stage of patients with lung cancer by modulating the transcriptional profile of normal lung.
Falvella FS; Frullanti E; Galvan A; Spinola M; Noci S; De Cecco L; Nosotti M; Santambrogio L; Incarbone M; Alloisio M; Calabrò E; Pastorino U; Skaug V; Haugen A; Taioli E; Dragani TA
Int J Cancer; 2009 Jun; 124(12):2880-5. PubMed ID: 19296538
[TBL] [Abstract][Full Text] [Related]
10. Functional FGFR4 Gly388Arg polymorphism contributes to oral squamous cell carcinoma susceptibility.
Chou CH; Hsieh MJ; Chuang CY; Lin JT; Yeh CM; Tseng PY; Yang SF; Chen MK; Lin CW
Oncotarget; 2017 Nov; 8(56):96225-96238. PubMed ID: 29221201
[TBL] [Abstract][Full Text] [Related]
11. Functional FGFR4 Gly388Arg polymorphism contributes to cancer susceptibility: Evidence from meta-analysis.
Xiong SW; Ma J; Feng F; Fu W; Shu SR; Ma T; Wu C; Liu GC; Zhu J
Oncotarget; 2017 Apr; 8(15):25300-25309. PubMed ID: 28445975
[TBL] [Abstract][Full Text] [Related]
12. Association of FGFR4 genetic polymorphisms with prostate cancer risk and prognosis.
FitzGerald LM; Karlins E; Karyadi DM; Kwon EM; Koopmeiners JS; Stanford JL; Ostrander EA
Prostate Cancer Prostatic Dis; 2009; 12(2):192-7. PubMed ID: 18762813
[TBL] [Abstract][Full Text] [Related]
13. Association of FGFR3 and FGFR4 gene polymorphisms with breast cancer in Chinese women of Heilongjiang province.
Jiang Y; Sun S; Wei W; Ren Y; Liu J; Pang D
Oncotarget; 2015 Oct; 6(32):34023-9. PubMed ID: 26431494
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of fibroblast growth factor receptor 4 polymorphisms on biochemical recurrence after radical prostatectomy in a Chinese population.
Chen L; Lei Z; Ma X; Huang Q; Zhang X; Zhang Y; Hao P; Yang M; Zhao X; Chen J; Liu G; Zheng T
Sci Rep; 2016 Sep; 6():33604. PubMed ID: 27640814
[TBL] [Abstract][Full Text] [Related]
15. Impact of FGFR4 Gene Polymorphism on the Progression of Colorectal Cancer.
Shiu BH; Hsieh MH; Ting WC; Chou MC; Chang LC; Huang CC; Su SC; Yang SF
Diagnostics (Basel); 2021 May; 11(6):. PubMed ID: 34071523
[TBL] [Abstract][Full Text] [Related]
16. Associations of
Chang JH; Lai TC; Yang PJ; Shih PC; Yang YC; Lee KL; Liu TC; Tsao TC; Yang SF; Chien MH
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33126605
[TBL] [Abstract][Full Text] [Related]
17. Effect of WW Domain-Containing Oxidoreductase Gene Polymorphism on Clinicopathological Characteristics of Patients with EGFR Mutant Lung Adenocarcinoma in Taiwan.
Li JP; Chang JT; Ju PC; Hsieh MH; Chao YH; Tsao TC; Hsieh MJ; Yang SF
Int J Environ Res Public Health; 2021 Dec; 18(24):. PubMed ID: 34948746
[TBL] [Abstract][Full Text] [Related]
18. Fibroblast growth factor receptor 4 mutation and polymorphism in Japanese lung cancer.
Sasaki H; Okuda K; Kawano O; Yukiue H; Yano M; Fujii Y
Oncol Rep; 2008 Nov; 20(5):1125-30. PubMed ID: 18949411
[TBL] [Abstract][Full Text] [Related]
19. Mutational analysis of EGFR and related signaling pathway genes in lung adenocarcinomas identifies a novel somatic kinase domain mutation in FGFR4.
Marks JL; McLellan MD; Zakowski MF; Lash AE; Kasai Y; Broderick S; Sarkaria IS; Pham D; Singh B; Miner TL; Fewell GA; Fulton LL; Mardis ER; Wilson RK; Kris MG; Rusch VW; Varmus H; Pao W
PLoS One; 2007 May; 2(5):e426. PubMed ID: 17487277
[TBL] [Abstract][Full Text] [Related]
20. Functional FGFR4 Gly388Arg polymorphism predicts prognosis in lung adenocarcinoma patients.
Spinola M; Leoni V; Pignatiello C; Conti B; Ravagnani F; Pastorino U; Dragani TA
J Clin Oncol; 2005 Oct; 23(29):7307-11. PubMed ID: 16061909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
